Next Article in Journal
Polish Medical Doctors’ Opinions on Available Resources and Information Campaigns concerning Antibiotics and Antibiotic Resistance, a Cross-Sectional Study
Next Article in Special Issue
Antibiotic Susceptibility and Resistance Genes in Oral Clinical Isolates of Prevotella intermedia, Prevotella nigrescens, and Prevotella melaninogenica
Previous Article in Journal
Antimicrobial Stewardship in Public-Sector Hospitals in KwaZulu-Natal, South Africa
Previous Article in Special Issue
Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Strategies to Combat Caries by Maintaining the Integrity of Biofilm and Homeostasis during the Rapid Phase of Supragingival Plaque Formation

by
Paola Hernández
1,
María C. Sánchez
1,2,
Arancha Llama-Palacios
1,2,
María J. Ciudad
1,2,* and
Luis Collado
1,2
1
Department of Medicine, Faculty of Medicine, University Complutense, 28040 Madrid, Spain
2
GINTRAMIS Research Group (Translational Research Group on Microbiota and Health), Faculty of Medicine, University Complutense, 28040 Madrid, Spain
*
Author to whom correspondence should be addressed.
Antibiotics 2022, 11(7), 880; https://doi.org/10.3390/antibiotics11070880
Submission received: 30 May 2022 / Revised: 24 June 2022 / Accepted: 28 June 2022 / Published: 30 June 2022
(This article belongs to the Special Issue Antimicrobial Strategies against Oral Pathogenic Bacteria and Biofilm)

Abstract

:
Bacteria in the oral cavity, including commensals and opportunistic pathogens, are organized into highly specialized sessile communities, coexisting in homeostasis with the host under healthy conditions. A dysbiotic environment during biofilm evolution, however, allows opportunistic pathogens to become the dominant species at caries-affected sites at the expense of health-associated taxa. Combining tooth brushing with dentifrices or rinses combat the onset of caries by partially removes plaque, but resulting in the biofilm remaining in an immature state with undesirables’ consequences on homeostasis and oral ecosystem. This leads to the need for therapeutic pathways that focus on preserving balance in the oral microbiota and applying strategies to combat caries by maintaining biofilm integrity and homeostasis during the rapid phase of supragingival plaque formation. Adhesion, nutrition, and communication are fundamental in this phase in which the bacteria that have survived these adverse conditions rebuild and reorganize the biofilm, and are considered targets for designing preventive strategies to guide the biofilm towards a composition compatible with health. The present review summarizes the most important advances and future prospects for therapies based on the maintenance of biofilm integrity and homeostasis as a preventive measure of dysbiosis focused on these three key factors during the rapid phase of plaque formation.

1. Introduction

Dental caries is considered one of the most prevalent human diseases, with the 2019 Global Burden of Disease Study estimating that close to 3.5 billion people worldwide experience oral disease, with caries in permanent teeth being the most common condition [1]. Globally, it is estimated that 2 billion people are affected by caries in permanent teeth and that 520 million children are affected by caries in primary teeth [1].
The main ethological component of dental caries consists of bacterial species (mainly streptococci, lactobacilli, and bifidobacteria) organized in sessile and highly specialized communities (the supragingival dental plaque) located in the proximal spaces and occlusal surfaces of the gingival margin [2,3,4,5,6,7]. Advances in the various omics techniques applied to the field of dental plaque have revealed that this oral ecosystem is inhabited by hundreds of bacterial species, most of which are considered commensal but include low levels of opportunistic pathogens that become the dominant species in caries-affected sites at the expense of health-associated taxa [8,9,10,11,12,13,14,15,16].
The conformation of the supragingival biofilm can be influenced by a wide range of factors, including the intake of food and drink, the availability of endogenous nutrients, drug treatments, the host’s immune system, and systemic diseases [17,18,19,20]. To respond to these factors, the oral microbiota maintains the internal stability of the community through homeostasis. However, certain ecological changes can induce modifications in the oral microbiota, leading to dysbiosis and dental caries [20,21,22,23,24]. Saliva plays an important role in oral microbial ecology by supplying nutrients and providing protection against colonization by nonoral organisms. However, reduced salivary flow has a major effect on the microbiota, resulting in increased growth/colonization by opportunistic pathogens, including non-oral bacteria and fungi. Certain systemic diseases, such as diabetes, also affect the oral microbiome, raising glucose levels in saliva and tissue and affecting bacterial nutrition. Similarly, excessive and/or frequent consumption of fermentable carbohydrates affects the composition of the oral bacterial community. The changes induced in these ecological ecosystems by the aforementioned factors are directly related to bacterial biofilm dysbiosis and the onset and progression of dental tissue damage [19,20]. If the microbiota changes, there will be a proliferation of aciduric microorganisms, mainly represented by Streptococcus, Lactobacillus, Bifidobacterium, Actinomyces, Veillonella, and certain yeasts, among others. Subsequently, the oral pH falls below the critical point for the demineralization process for an increased period, resulting in dental tissue demineralization [20,21,23,24].
The biofilm phenotype of oral-caries-causing bacteria provides them with substantial resistance to anticaries therapies. Thus, for example, mechanical oral hygiene can limit microbial growth but does not completely eliminate the biofilm, which recomposes itself in a few hours [23,25,26]. Pharmacological treatments based on antibiotic and antiseptic therapy are less effective against bacteria organized in biofilm than against planktonic phenotypes, not exempt, in addition, to unwanted effects [18,26,27]. Despite the knowledge generated about the onset and evolution of bacterial dysbiosis as a caries-causing agent, there are few therapies focused on combining more conventional routine mechanical treatment, such as tooth brushing or rinsing assisted by antiseptic compounds to control the natural growth of dental plaque, with newer methods that act on the remaining percentage of plaque, which has survived and will regenerate in a few hours, helping to maintain homeostatic capacity.
In this review of the literature, we focus on describing state-of-the-art methods showing the most important advances and future prospects for this type of therapy based on the maintenance of biofilm integrity and homeostasis as a preventive measure of dysbiosis.

2. From Homeostatic to Dysbiotic Supragingival Biofilm

The mouth is a warm and humid habitat that exposes numerous surfaces, including the mucosa, which are covered by keratinized and nonkeratinized stratified squamous epithelium, the papillary surface of the tongue dorsum or the hard structures of the teeth, which lie above (supragingival) and below (subgingival) the gingival margin, all of them susceptible to colonization by a wide variety of microorganisms. Teeth have a unique characteristic in the human body, providing major advantages for colonization by microorganisms: a nonscaling rigid surface exposed to an environment abundant in nutrients, facilitating microorganisms’ organization into sessile communities [2,4,5]. Despite its advantages, this region also presents nonfavorable conditions for microorganisms, which induce bacteria to aggregate into biofilms and thereby survive in the extreme conditions in a continuously changing environment caused by changes in fluids such as saliva and crevicular fluid if they access the subgingival zone, oxygen concentration gradients, environmental stress, invasion by other competing microorganisms, and the unbalanced availability of nutrients derived from eating and chewing [5,17,28].
Supragingival biofilm formation occurs within a few hours in a series of sequential but arguably almost simultaneous events (Figure 1). The normal development of dental plaque starts with the selective adsorption of hydrophobic macromolecules onto the tooth surface —constantly bathed in saliva rich in glycoproteins and other proteins— to create a conditioning film. The glycoproteins and proteins in the conditioning film serve as ligands, attracting specific species of Gram-positive and Gram-negative bacteria mainly from the genera Streptococcus, Actinomyces, Capnocytophaga, Eikenella, Haemophilus, Prevotella, Propionibacterium, and Veillonella (Figure 1a) [28,29,30].
Once the surface has been successfully colonized by these pioneer bacteria, the biofilm has already begun to form and will start differentiating as a highly structured community. To do this, the bacteria (and, consequently, the biofilm) enter a logarithmic growth phase (Figure 1b). During this intermediate phase, there is faster growth in the evolution of the biofilm of Gram-positive bacteria compared to Gram-negative species. Interspecies communication, now mediated by the quorum-sensing (QS) system, will facilitate biofilm differentiation, influencing bacterial metabolism and leading to extracellular polysaccharide matrix formation (EPS) and community maturation [28,29,31].
The union and growth of the first colonizers on the dental surface provides new ligands for colonization by other species that adhere successively, mainly from the genera Corynebacterium, Eubacterium, and Fusobacterium, among others [30,32,33,34]. At this stage, a high bacterial density will have been reached, which entails significant oxygen consumption by the bacteria, thereby generating oxygen gradients inside the biofilm structure (Figure 1c). An anaerobic environment then begins to develop, which will favor the growth of these secondary colonizers, which have stricter anaerobic requirements for their growth. Anaerobic taxa tend to be in the interior, whereas facultative or obligate aerobes are located at the periphery of the consortium. Consumers and producers of certain metabolites, such as lactate, tend to be near each other [33,34,35]. Such highly organized spatial arrangements are likely to result from and facilitate a large variety of interspecies interactions, including the formation of metabolic networks [27,34,35].
Synergistic and antagonistic interactions with neighboring species will be established at this time in the biofilm, generating an exchange of food and oxygen that strengthens the biofilm matrix and creating the ideal environment for the coexistence of bacteria with diverse survival mechanisms. The biofilm thereby reaches a mature state and equilibrated homeostasis (Figure 1d) [30,32]. Synergism includes the collective degradation of salivary glycoproteins by microbial consortia, in which complementary enzymatic activities allow the utilization of mucins in saliva as an energy source or of food chains in which a metabolic product of one species is used as the primary energy source for a partner species. Antagonistic interactions are mediated by the production of bacteriocins and hydrogen peroxide (H2O2) [36,37,38]. When there is a balance between acid production and alkaline compensation, the biofilm enters into symbiosis with the host, establishing a neutral pH between the biofilm and the ecosystem. This condition allows the biofilm to be stable in its bacterial composition and helps regulate and strengthen the inflammatory response provided by the host’s immune cells to attack by pathogenic bacteria. At this mature phase, the biofilm and host can coexist in harmony [27,39].
The last step in the development of a biofilm is the release and migration of bacteria to other surfaces, which causes a reorganization of the microbial structure and composition of the biofilm [3,30,32].
Normal supragingival biofilm development can, however, be affected by the various aforementioned factors, which the bacterial community will be unable to counteract by the homeostatic capacity, and, as a result of the ecological changes, the microbiota will be modified. An increase in carbohydrates in the environment to be metabolized by bacteria and the subsequent generation of a low environmental pH can change the composition and metabolic properties of the bacterial communities in dental plaque, leading to enrichment of acid producers (acidogenic) and acid-tolerant (aciduric) microorganisms [21,40]. The overgrowth of these bacteria and the excessive carbohydrate fermentation modify the oxygen gradient, creating a more anaerobic environment, thereby favoring rapid growth of pathogenic genera such as Porphyromonas, Tannerella, Treponema, Capnocytophaga and Aggregatibacter, which were present in very low latent numbers and were waiting for favorable conditions to grow in the biofilm [35,40]. In this dysbiotic condition, the supragingival biofilm could be the initial point for developing diseases other than caries, such as periodontal and peri-implant diseases [21,38].

3. Benefits Derived from Biofilms in Homeostasis and the Disadvantages of Dysbiosis

The supragingival biofilm in homeostasis promotes oral health, providing advantages to the bacterial community and the host. In contrast, its dysbiosis can cause certain deleterious effects on both.
Resident commensal microbiota behave as a barrier against invasion by other competing microorganisms, preventing the colonization of this niche. Streptococci are the main early colonizers due to their ability to bind to any cell, whether human or bacterial [41]. Even at the onset of biofilm formation, species such as Streptococcus mitis, Streptococcus sanguinis, and Streptococcus cristatus use arginine deiminase to suppress the expression and production of fimbrial proteins and gingipains in pathogenic bacteria such as Porphyromonas gingivalis and reduce their adhesion [42,43,44].
The buffer capacity of saliva also benefits from commensal microbiota. Species such as Streptococcus salivarius, S. mitis, Streptococcus gordonii, S. sanguinis, S. cristatus, and Actinomyces naeslundii buffer the acid produced by certain cariogenic bacteria through the salivary lactoperoxidase system, which increases H2O2 and the pH of saliva. This action favors the saliva’s ability to neutralize acid and maintain the demineralization–remineralization process [36,45,46].
Commensal bacteria in homeostasis, through antagonistic bacterial interactions mediated by the production of bacteriocins and H2O2, can also affect community association, as occurs with S. mitis and/or Haemophilus parainfluenzae, which enhance the behavior of other caries-related streptococci [47,48]. Commensal bacteria also help reduce nitrate, which is essential for homeostasis and cardiovascular health. Through the action of nitrate reductase enzymes, commensal facultative anaerobic bacteria located in the tongue can reduce nitrate to nitrite, which functions as a vasodilator and antihypertensive when it passes into the bloodstream [49,50].
Biofilm in homeostasis strengthens the immune response and provides important benefits to the host. Oral streptococci suppress cytokine expression in epithelial cells, which reduces the inflammation of epithelial cells in oral mucosa and stimulates type I and II interferon response [51,52,53]. Commensal Lactococcus lactis also produces an antibiotic substance called nisin, which helps reduce tumor formation, cancer cell migration, squamous cell invasion, and dental caries [54,55,56,57,58].
In contrast, dysbiosis represents the alteration of the symbiotic state of the oral microbiome on the supragingival surface of the teeth [20,38]. Most of the enzymatic activities of bacteria that allow them to adapt to an environment are influenced by the acidification of the environment. When there is a high and constant consumption of carbohydrates and fermentable sugars, the pH of the medium alters from an alkaline condition (6.0–7.0)—favorable for commensal bacteria—to a more acidic 5.5, which decreases the flow and buffering capacity of saliva [24,59], resulting in changes in the bacterial composition. These changes favor the rapid growth of Streptococcus, Actinomyces, and Lactobacillus, which metabolize carbohydrates more easily, degrading glucose into pyruvate, lactate, and acetate, generating an anaerobic environment [9,59]. In this scenario, the growth of certain species of P. gingivalis, Treponema denticola, Tannerella forsythia, and Aggregatibacter actinomycetemcomitans also produce other acids, such as lactic and formic acid [9,59,60], which complicate the situation. The accumulation of more diverse microbiota tolerant to an acidic environment on the supragingival surface of the tooth, along with elevated carbohydrate fermentation, disrupts the demineralization–remineralization balance of dental tissues, facilitating the onset of carious lesions [23,40,60,61].
The dysbiosis of supragingival biofilm also decreases the H2O2 production of S. gordonii and reduces its competitiveness against Streptococcus mutans [37,45]. Likewise, the dysbiosis promotes the growth of cariogenic bacteria, such as S. mutans, Lactobacillus, Actinomyces, and Veillonella [21,39,40]. These bacteria produce lactic acid, which alters the exopolysaccharide matrix and modifies the chemical gradients that contribute to decreasing the pH of the medium. These alterations affect the genotypic and phenotypic selection of the microorganisms within the biofilm consortium, increasing their cariogenicity and causing the demineralization of dental tissues. If left untreated, this can lead to more advanced oral pathologies, such as pulp involvement, that can lead to abscess formation [38,61].

4. Strategies to Combat Caries by Maintaining the Integrity of Biofilm and Homeostasis during the Rapid Phase of Supragingival Plaque Formation

In view of the aforementioned, adequate methods of homeostatic maintenance of oral biofilms are currently a subject of research, as it could prevent the onset and progression of caries.
Dental plaque is mainly affected by oral hygiene. To effectively control plaque, tooth brushing is combined with toothpaste or mouthwashes that contain a variety of chemical agents; however, this does not provide optimal plaque removal [62], an issue that has been extensively reviewed, resulting in the biofilm remaining in an immature state with high proportions of early-plaque-forming bacteria, particularly streptococci. In the rapid phase of supragingival plaque formation from firmly attached bacteria on a previously cleaned surface, bacteria double in number in 3–4 h [63]. Adhesion, nutrition, and communication are essential in this phase for bacteria that have survived those adverse conditions to rebuild and reorganize the biofilm. These three bacterial biofilm development factors can be the target of preventive strategies to guide the biofilm towards a composition compatible with health and equally healthy metabolic behavior (Figure 2). The preventive strategies at this phase mainly act on the primary colonizers—those that can quickly begin biofilm restoration. This review therefore summarizes the most important advances and future prospects for this type of therapeutic approach aimed at restoring the ecological balance at this immature state to prevent dysbiosis.

4.1. Preventive Approaches Related to Initial Bacterial Adhesion

The initial adhesion phase is a crucial step in designing strategies to intervene in the development of a cohesive and stable plaque structure compatible with health. However, this is a very ambitious project. Although various mechanisms have been described to inhibit specific bacterial adhesion and even complete biofilm attachment, the bacterial community as a whole has a wide variety of alternative strategies that allow it to circumvent such approaches. Several studies have presented compounds that by various means inhibit bacterial adhesion in vitro. This is the case for graft copolymer M239-144, which acts significantly on the hydrophobicity-mediated adhesion of Streptococcus species but does so less effectively in vivo [64,65]. Natural polyphenols and other active plant-derived compounds have also been studied. Current studies have focused on evaluating the ability of active plant-derived compounds to reduce the adhesion of pathogens and inhibit the formation of biofilms in disease development processes [66,67]. Phytochemicals, mainly polyphenols and flavonoids, have been widely studied to manage the growth inhibition, acid production, and adhesion of pathogens during biofilm formation and to prevent dysbiosis [68].

4.1.1. Polyphenols

Various natural sources provide polyphenols with antimicrobial effectiveness. Green tea (Camellia sinensis) contains epigallocatechin gallate, a polyphenol with a strong antimicrobial effect capable of suppressing the acid production of S. mutans [68]. In addition, this polyphenol promotes the adhesion of other beneficial streptococci, controlling the efficacy and safety between the medium and oral homeostasis. Black tea maintains the pH of the medium and inhibits bacterial glycolysis in the supragingival biofilm [67].
Blueberries (Vaccinium macrocarpon) are also rich in polyphenols, such as proanthocyanidins, that prevent the adhesion of pathogens such as Escherichia coli and Helicobacter pylori to mucous membranes [69]. Yamanaka A. et al. [70] described the capacity of cranberry juice in preventing the progression of supragingival plaque to dental caries via the reduction in the activity of fructosyltransferase and glucosyltransferase enzymes in charge of glucose metabolism and the formation of the EPS matrix. Cranberry juice also inhibits the adhesion of S. mutans to hydroxyapatite. These inhibitory and antibacterial effects were also observed with other natural extracts, such as clove methanol and aqueous and clove methanol extracts of Syzygium aromaticum and Myrtaceae, according to Rahim Z. et al. [71]. In a study by Karygianni [72], Pistacia lentiscus and Olea europaea (oleuropein, maslinic acid, hydroxytyrosol, oleocanthal, oleacein) extracts also reduce the acidogenicity and metabolic activity of oral biofilms, affecting P. gingivalis and Fusobacterium nucleatum. Philip N et al. [73] and other authors observed that berries inhibited the growth of S. mutans.

4.1.2. Flavonoids

Numerous flavonoids have been analyzed; at the oral biofilm level, however, only a few have shown efficacy in maintaining homeostasis. Artocarpine and artocarpesin from Artocarpus heterophyllus have shown effectiveness in inhibiting the growth of oral cariogenic bacteria, such as S. mutans and certain Actinomyces and Lactobacillus species [68]. Other flavonoids with a high capacity to interfere with the uptake of glucose and other metabolites in S. mutans and other cariogenic bacteria are the phytoalexin flavones and the erycristagallin present in Erythrina variegata (Leguminosae) [68]. The therapeutic effect of baicalein (5,6,7-trihydroxyflavone), a flavonoid present in Scutellaria baicalensis and Scutellaria lateriflora, is being evaluated but is believed to affect the expression of several virulence genes that interact with the genes of S. mutans, which would alter the progression of biofilm to caries [74]. Propolis contains flavonoids which have conferred good antimicrobial activity against a number of oral bacteria and inhibition of the adherence of S. mutans and Streptococcus sobrinus [68].

4.1.3. Other Natural Active Compounds with Anti-Adhesion Biofilm Effect

Rhodiola (Rhodiola rosea) is a plant whose extract can inhibit S. mutans when combined with other extracts from, for example, Psidium sp., Mangifera sp. and Mentha sp. These inhibit the adhesion of S. mutans and prevent acid production that can change the medium’s pH [75,76]. When combined with Psidium sp., Mangifera sp., and Mentha sp. natural extracts, a reduction has been observed in the hydrophobicity of the cell surfaces of S. sanguinis and S. mutans, reducing adherence in biofilm formation. Psidium sp. extract has also been observed to inhibit adherence of these bacteria in the biofilm, while Mangifera sp. decreases the initial pH change in mixed populations of S. sanguinis and S. mutans [77].
Babchi (Psoralea corylifolia, Fabaceae) contains bakuchiol, which has shown antibacterial activity against Gram-positive and Gram-negative bacteria. In oral biofilms, bakuchiol inhibits the growth and adhesion of S. mutans. Another terpene with antimicrobial activity is Sagittaria A-D from the arrowhead plant (Sagittaria sagittifolia), which has shown activity against S. mutans, A. naeslundii, and Actinomyces viscosus [68].
Xylitol—a sugar alcohol found naturally in plants such as birch (Betula), bark plants, and fruits—has anticariogenic properties, inhibits S. mutans, S. saliviarius, and is widely included in toothpastes, mouthwashes, and foods to prevent tooth decay [78].
In addition to the natural active compounds already mentioned, other herbs described in different studies, such as bloodroot, chamomile, caraway, myrrh, echinacea, rosemary, sage, aloe vera, thyme, and other useful herbs in dentistry may be good alternatives to current treatments for oral health problems, but clearly, more research is required to study their effectiveness on caries by maintaining the integrity of biofilm and homeostasis at the rapid phase of supragingival plaque formation [79].

4.2. Preventive Approaches Related to Bacterial Nutrition

The primary nutritional source for oral bacteria at the supragingival level is saliva [28,30,32], although the host’s diet is used by the bacteria in dental plaque. Bacteria attached to the tooth surface use salivary glycoproteins and dietary carbohydrates (mainly by streptococci) and proteins, which are degraded mostly by anaerobic Gram-negative proteolytic bacteria and amino acids and consumed by bacteria with aminopeptidase activity [80].

4.2.1. Preventive Approaches Related to Host Diet as Bacterial Nutrition Source

Scientific evidence has shown that an increased frequency of carbohydrate intake will favor the cariogenic process, but other properties, such as food texture and the amount of time food remains in the oral cavity, should be taken into account in the disease’s progression [28,81]. For example, the consumption of soft drinks and sugary beverages decreases the pH of dental plaque in vivo [81,82]. Acids are neutralized by saliva, and it is estimated that saliva can neutralize the pH of plaque 20–30 min after consumption. However, if the consumption of acids is repetitive, the saliva’s capacity decreases, and the time for the bacteria to act is extended, leaving the tooth surface susceptible to the development of caries. The same situation occurs with sugary and sticky foods that remain longer on the tooth surface, releasing acids slowly and constantly so that the bacteria continue to metabolize the acids and causing caries to progress [38,81,82].
Surprisingly, a specific group (the amino sugars) related to carbohydrates can be considered a strategy for caries control and prevention focused on homeostatic balance. This group of compounds includes sugar molecules that contain an amino group instead of a hydroxyl group in one of their radicals and those derivatives of amines that contain sugars, such as N-acetylglucosamine and sialic acid, which—although they formally do not contain primary amines—are also considered amino sugars [83,84]. It has been reported that amino sugars can enhance the beneficial properties of oral streptococci and can moderate the cariogenicity of oral biofilms without disturbing homeostatic balance [40]. Amino sugars such as glucosamine and N-acetylglucosamine can increase the competitiveness of S. gordonii against S. mutans, reducing the viability of S. mutans against other commensal species. Streptococci can also metabolize amino sugars and arginine deiminase more easily, increasing H2O2 production and releasing ammonia, which raises the medium’s pH [80,83,84].

4.2.2. Preventive Approaches Related to Saliva as a Bacterial Nutrition Source

In terms of saliva as the oral bacteria nutrition source, prebiotics play a relevant role in prevention and are defined as a substance or molecule that can be used by microorganisms and can alter bacterial growth or metabolic activity to confer benefits to the host. In the oral cavity, prebiotics help nonpathogenic bacteria balance the oral microbiome, showing promising results in combating the progression of biofilm dysbiosis [51,85]. In certain cases, these benefits for the host will not only include control of plaque homeostasis but will also have systemic repercussions.
Nitrate is being studied as a possible prebiotic to beneficially modify plaque microbiota and play a protective role in maintaining cardiovascular health [49,50]. Through the enterosalivary circuit, nitrate from the diet or taken as a prebiotic supplement is absorbed in the stomach and passes into the bloodstream to later return in a concentrated form in the saliva, where it is reduced to nitrite by oral bacteria to ultimately become nitric oxide [50,86]. Nitrate supplementation has been observed in vivo to induce certain changes in the microbiota, such as an increase in nitrate-reducing bacteria, including Neisseria and Rothia, which are obligate aerobic bacteria related to oral health [87]. Nitrate supplementation has also been shown to have significant effects in lowering blood pressure [49,50,86].
Due to its ability to act during the initial phase of biofilm development to the detriment of the progression of dysbiosis towards caries, the amino acid arginine (L-arg) is also postulated as a good prebiotic in the oral cavity [44,80]. L-arg, present in peptides and proteins of salivary secretions [88], is metabolized by the arginine deiminase system (ADS) to release ornithine, ammonia, and carbon dioxide to counteract the acid production of the medium, protect cells from acidification, and facilitate the generation of adenosine triphosphate for the growth and maintenance of dental biofilms [44,88]. L-arg has been considered an alkaline substrate, and certain species such as S. gordonii, Streptococcus parasanguinis, Streptococcus intermedius, Streptococcus australis, and S. cristatus contain ADS and catabolize it, promoting the alkalinity of the biofilm and inhibiting S. mutans [89,90,91]. In addition to affecting the change in the medium’s pH, L-arg can reduce adherence to the substrate and prevent bacterial congregation between Prevotella oris and P. gingivalis, inhibiting the growth of species such as S. mutans, S. sobrinus, and S. sanguinis while not affecting other bacteria. Promoting a change in the microbial community is therefore an alternative to favoring alkaline-base-producing bacteria and preventing the progression of caries [92,93].
Other compounds that have shown efficacy as prebiotics in other areas of the human body are currently being evaluated as prebiotics in the mouth. Substances such as glucomannan hydrolysate increase the growth of Lactobacillus acidophilus, which has probiotic properties and reduces the growth of S. mutans [94,95]. Similarly, lactitol, known as a prebiotic for gastrointestinal health, was evaluated by Slomka V. et al. [96], showing a specific increase in the growth of S. salivarius and no growth of pathogenic bacteria.
Sugar alcohols, such as arabinose, xylose, maltitol, and xylitol, have also been proposed as prebiotics due to their ability to act on acid production by saccharolytic bacteria, thereby reducing the risk of caries [78,97,98,99,100,101]. Kojima Y et al. [102] observed a favored growth of lactobacilli, which inhibited the growth of pathogenic species such as Candida albicans, S. mutans, and P. gingivalis.
The amino acid proline has also been postulated as a prebiotic. In vitro assays have indicated that proline affects host–pathogen interactions by modulating cell signaling and osmotic stress either as an antibacterial molecule or as a prebiotic [9,103]. Studies have also reported that a proline-containing peptide (tripeptide Ile-Pro-Ile (described as diprotin A)) led to increased resistance in biofilms to sucrose-induced decreases in pH [95,96]. Furthermore, the behavior of methionine--proline dipeptide has been evaluated, and it has been observed that methionine-proline succeeded in changing the composition of an oral biofilm model by reducing the pathogenic species to a predominantly beneficial species [104].

4.3. Preventive Approaches Related to Bacterial Coaggregation and Communication

4.3.1. Probiotics and Supragingival Homeostasis

Probiotics in the oral cavity are considered microorganisms that benefit oral health and have the potential to intervene in biofilm formation and in the niche’s pH among other actions, rebalancing the dysbiosis [102,105,106,107] but also producing effects on the host’s general health. Probiotics in the oral cavity act through three important mechanisms: direct bacterial inhibition through the production of antimicrobial substances, competition for nutrients and binding sites on host cell surfaces that prevent coaggregation, and modulation of the humoral and cellular immune response [107].
In caries prevention, probiotics can colonize the oral cavity and displace cariogenic bacteria. In general, probiotics can produce various antimicrobial substances—such as bacteriocins and bacteriocin-like peptides, lactic acid, and H2O2—that increase the medium’s pH and activate immune response cells such as macrophages, neutrophils, and natural killer cells to attack pathogens [107,108,109,110,111,112].
Several bacterial species of extraoral and intraoral origin have been proposed as oral probiotics, classified according to genus, species, and strain. Several species of the genus Streptococcus can attenuate the inflammatory response by decreasing interleukin-8 production by oral keratinocytes when attacked by A. actinomycetemcomitans [111,112]. The probiotics based on S. cristatus and Streptococcus A12 species produce proteases that interrupt bacteriocin production in S. mutans and produce antibacterial factors, such as organic acids and H2O2, that prevent the production of pathogenic bacterial compounds [42,48,108]. Other species, such as S. gordonii and S. sanguinis, produce H2O2, which inhibits the secretion of bacteriocins and interferes with intracellular signaling pathways to combat S. mutans [36,108,113]. The study by Thurnheer et al. [114] showed that Streptococcus produces bacteriocins that kill cryogenic bacteria and dampen salivary pH, preventing tissue demineralization. Similarly, the S. salivarius strain produces bacteriocins, such as streptin and salivaricin, with inhibitory power over other microorganisms. S. salivarius M18 produces urease and dextranase enzymes that neutralize the acidity of saliva and inhibit the microorganisms present in oral biofilms. Streptococcus oligofermentans has shown strong adhesion and a low capacity to metabolize carbohydrates but can produce H2O2 to inhibit pathogens such as S. mutans [115,116].
Various species of the genus Lactobacillus—including Lactobacillus reuteri, Lactobacillus brevis, Lactobacillus rhamnosusGG, Lacticaseibacillus casei, Lactobacillus plantarum, and L. lactis—have been reported to produce inhibitory substances such as ammonia that buffer the pH in saliva to prevent the growth of S. mutans [107,109,117]. Furthermore, as already mentioned, L. lactis produces nisin, a natural antimicrobial peptide highly active against Gram-positive bacteria with a potential role as a caries-preventive agent in the oral cavity with an effect on cariogenic bacteria and root canal pathogens. Nisin produce inhibition of common cariogenic-relevant bacteria such as S. sanguinis, Lactobacillus fermenti, L. acidophilus and S. mutans, which showed significant cell damage after nisin treatment. This confers considerable potential for used as an antibacterial agent to prevent dental caries and makes L. lactis a promising probiotic strain [56,57,58].
Other genera and species—such as Neisseria, Streptococcus sp. A12, S. sanguinis BCC23, Actinomyces, Veillonella, Granulicatella, diverse species of Bifidobacterium (animalis, lactis, bifidum, longum), and Bacillus coagulans—are currently being analyzed for their relationship to the recovery of symbiosis in biofilms [105,107,118,119,120].
Studies on the use of probiotics in the oral cavity are ongoing, and probiotics have demonstrated a beneficial role in preserving health; however, their effects are transitory, and strategies such as the use of prebiotics that enhance probiotics’ therapeutic effects are currently being researched [102,107,119].
Due to the rapid elimination of probiotic bacteria from the oral mucosa, the use of mucoadhesive and prebiotic polymer composites has been proposed as a strategy to prolong the contact time between the bacteria and the oral mucosa without delaying disintegration. One of these polymers that facilitates the prolongation and stability of probiotics in the mucosa is nanochitosan [121,122], which has been used to release salivary proteins and electrolytes, prolong the permanence of probiotics and therefore prebiotics in the mucosa, improve the pH of the medium, and prevent oral diseases [122,123]. Studies have shown that nanochitosan accompanied by sodium alginate and used as a coating for quercetin starch prolongs the resistance of L. acidophilus, L. rhamnosus GG, and other species such as B. longum [121,122,123,124,125,126].

4.3.2. QS System Inhibition

The development and maturation of biofilms is regulated by various chemical communication systems between bacteria, known as the QS. When bacteria receive stimuli, the QS regulates gene expression by secreting specific signaling molecules, called autoinducers, which favor the development and communication of bacterial communities and incite coordinated behavior in the population. This mechanism also induces changes in the surface and in bacterial metabolism, which help form the biofilm matrix from the extracellular polysaccharide substances secreted by the bacteria [30,127,128].
The three most common autoinducer molecules are autoinducing peptides (AIP) produced by Gram-positive bacteria: autoinducer-2 (AI-2), present in Gram-positive and Gram-negative bacteria, and acyl homolactones (AHL), produced mainly by Gram-negative bacteria. A better understanding of the functioning of QS in dysbiotic processes has allowed the development of new strategies for controlling pathogen growth in oral biofilms. QS inhibition by degradation or inhibition of the synthesis of the signaling molecule IAs and interference of its functions in biological treatment systems are being considered as strategies. The use of a bacterial cell extract with QS enzymes that act extracellularly to degrade autoinducer molecules can be used to inhibit IA-2 and prevent biofilm formation in S. mutans [129,130,131]. Lactonase, acylase, decarboxylase, and deaminase have the ability to degrade AHL in biofilm formation [132]. D-galactose has been shown to reduce biofilm formation in F. nucleatum, P. gingivalis, and T. forsythia by blockading the AI-2 receptor [131,132,133]. AIP can affect intercellular communication and biofilm formation and promote microbial resistance. In the Streptococcus genus, a competence-stimulating peptide (CSP) has been identified that corresponds to AIP signaling. CSP-mediated QS is believed to inhibit and control mutacin (bacteriocin) transcription in S. mutans. When synthesized by commensal bacteria such as Streptococcus oralis and A. naeslundii, AI-2 allows beneficial growth among bacteria. However, AI-2 is mostly produced by pathogens such as F. nucleatum, P. gingivalis, and Prevotella intermedia, delaying the growth of commensal bacteria. AI-2 would therefore favor the change from a commensal to a pathogenic biofilm community. The role of AHL in oral biofilm formation has recently been demonstrated. This autoinducer has been identified in samples of saliva, tongue cells, and oral cavity biofilms containing isolated strains including Enterobacter sp., Klebsiella pneumoniae, Pseudomonas putida, and Citrobacter amalonaticus [129,132,133].
Although these new approaches have shown an ability to inhibit QS, their exact role and the mechanisms of QS inhibition have not been precisely defined, and further studies are required [129].

4.3.3. Glucose Oxidase Nanohybrid (Dex-IONP-Gox)

A bifunctional nanohybrid system for selectively targeting pathogenic bacteria and preserving commensal bacteria in oral biofilms has recently been described. The system is composed of a glucose oxidase (GOx) that is covalently attached to a dextran-coated iron oxide nanoparticle (Dex-IONP). GOx can catalyze intracellular glucose and oxygen to increase H2O2 in the biofilm, while Dex-IONP decomposes H2O2 into oxygen ions, free radicals that induce reactive oxygen species with capacity for inhibit bacteria and degrade the extracellular polysaccharide substance matrix [134]. The study by Yue Huang et al. [134] showed that Dex-IONP-GOx preferentially binds and kills S. mutans more effectively than commensal S. oralis, an important strategy given that it does not disturb the commensals and host microbiota. The strategy also showed efficacy in reducing caries when compared with chlorhexidine without producing side effects on tissues and without affecting the gastrointestinal microbiome.

5. Conclusions

Dental caries is a highly prevalent multifactorial disease that results from the interaction between cariogenic bacteria, a diet rich in fermentable carbohydrates, and a susceptible host. Dental caries is mainly combated with daily oral hygiene through various strategies, which even today are not entirely effective. Undesirable effects such as pigmentation and bacterial resistance have therefore increased. There is therefore a need for new therapeutic pathways that focus on preserving the balance in the oral microbiota, applying strategies to combat caries while maintaining biofilm integrity and homeostasis in the rapid phase of supragingival plaque formation from bacteria firmly adhered to a previously clean surface.
Long-term prevention will only be achieved if oral homeostasis is maintained by controlling the factors that favor dysbiosis. If these mechanisms are not addressed, the disease might reappear. This literature review discussed the general benefits of these strategies and their mechanisms of action in the fight against oral pathogenic bacteria in the early stages of biofilm formation after the daily hygiene process. More studies are needed to better understand the mechanisms of action, toxicity, and effectiveness of these strategies with the aim of developing commercial products that are easily accessible to the entire population and thus mitigate the high rates of tooth loss due to caries and improve quality of life.

Author Contributions

Conceptualization, P.H. and M.C.S.; literature review and data analysis, P.H. and M.C.S.; writing—original draft preparation, P.H.; writing—review and editing, P.H., M.C.S., and A.L.-P.; supervision, M.J.C. and L.C. All authors contributed to the article and approved the submitted version. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Global Burden of Disease Collaborative Network. Global Burden of Disease Study; Institute of Health Metrics and Evaluation (IHME): Seattle, WA, USA, 2019. [Google Scholar]
  2. Marsh, P.; Head, D.A.; Devine, D.A. Dental plaque as a biofilm and a microbial community-implications for treatment. J. Oral Biosci. 2015, 57, 7. [Google Scholar] [CrossRef]
  3. Lif Holgerson, P.; Ohman, C.; Ronnlund, A.; Johansson, I. Maturation of Oral Microbiota in Children with or without Dental Caries. PLoS ONE 2015, 10, e0128534. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Marsh, P.D.; Moter, A.; Devine, D.A. Dental plaque biofilms: Communities, conflict and control. Periodontol 2000 2011, 55, 16–35. [Google Scholar] [CrossRef] [PubMed]
  5. Marsh, P.D. Dental plaque as a microbial biofilm. Caries Res. 2004, 38, 204–211. [Google Scholar] [CrossRef] [PubMed]
  6. Aas, J.A.; Griffen, A.L.; Dardis, S.R.; Lee, A.M.; Olsen, I.; Dewhirst, F.E.; Leys, E.J.; Paster, B.J. Bacteria of dental caries in primary and permanent teeth in children and young adults. J. Clin. Microbiol. 2008, 46, 1407–1417. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Eriksson, L.; Lif Holgerson, P.; Esberg, A.; Johansson, I. Microbial Complexes and Caries in 17-Year-Olds with and without Streptococcus mutans. J. Dent. Res. 2018, 97, 275–282. [Google Scholar] [CrossRef] [PubMed]
  8. Zijnge, V.; van Leeuwen, M.B.; Degener, J.E.; Abbas, F.; Thurnheer, T.; Gmur, R.; Harmsen, H.J. Oral biofilm architecture on natural teeth. PLoS ONE 2010, 5, e9321. [Google Scholar] [CrossRef] [Green Version]
  9. Sanchez, M.C.; Velapatino, A.; Llama-Palacios, A.; Valdes, A.; Cifuentes, A.; Ciudad, M.J.; Collado, L. Metataxonomic and metabolomic evidence of biofilm homeostasis disruption related to caries: An in vitro study. Mol. Oral Microbiol. 2022, 37, 81–96. [Google Scholar] [CrossRef]
  10. Johansson, I.; Witkowska, E.; Kaveh, B.; Lif Holgerson, P.; Tanner, A.C. The Microbiome in Populations with a Low and High Prevalence of Caries. J. Dent. Res. 2016, 95, 80–86. [Google Scholar] [CrossRef]
  11. Mason, M.R.; Chambers, S.; Dabdoub, S.M.; Thikkurissy, S.; Kumar, P.S. Characterizing oral microbial communities across dentition states and colonization niches. Microbiome 2018, 6, 67. [Google Scholar] [CrossRef]
  12. Mira, A.; Simon-Soro, A.; Curtis, M.A. Role of microbial communities in the pathogenesis of periodontal diseases and caries. J. Clin. Periodontol. 2017, 44 (Suppl. 18), S23–S38. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Munson, M.A.; Banerjee, A.; Watson, T.F.; Wade, W.G. Molecular analysis of the microflora associated with dental caries. J. Clin. Microbiol. 2004, 42, 3023–3029. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Tanner, A.C.; Kent, R.L., Jr.; Holgerson, P.L.; Hughes, C.V.; Loo, C.Y.; Kanasi, E.; Chalmers, N.I.; Johansson, I. Microbiota of severe early childhood caries before and after therapy. J. Dent. Res. 2011, 90, 1298–1305. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Wake, N.; Asahi, Y.; Noiri, Y.; Hayashi, M.; Motooka, D.; Nakamura, S.; Gotoh, K.; Miura, J.; Machi, H.; Iida, T.; et al. Temporal dynamics of bacterial microbiota in the human oral cavity determined using an in situ model of dental biofilms. NPJ Biofilms Microbiomes 2016, 2, 16018. [Google Scholar] [CrossRef] [PubMed]
  16. Ximenes, M.; Armas, R.D.; Triches, T.C.; Cardoso, M.; Vieira, R.S. Structure of the Bacterial Community in Different Stages of Early Childhood Caries. Oral Health Prev. Dent. 2018, 16, 369–373. [Google Scholar] [CrossRef] [PubMed]
  17. Haffajee, A.D.; Teles, R.P.; Patel, M.R.; Song, X.; Veiga, N.; Socransky, S.S. Factors affecting human supragingival biofilm composition. I. Plaque mass. J. Periodontal Res. 2009, 44, 511–519. [Google Scholar] [CrossRef]
  18. Rath, S.; Bal, S.C.B.; Dubey, D. Oral Biofilm: Development Mechanism, Multidrug Resistance, and Their Effective Management with Novel Techniques. Rambam Maimonides Med. J. 2021, 12, e0004. [Google Scholar] [CrossRef]
  19. Featherstone, J.D. The continuum of dental caries—Evidence for a dynamic disease process. J. Dent. Res. 2004, 83, C39–C42. [Google Scholar] [CrossRef]
  20. Radaic, A.; Kapila, Y.L. The oralome and its dysbiosis: New insights into oral microbiome-host interactions. Comput. Struct. Biotechnol. J. 2021, 19, 1335–1360. [Google Scholar] [CrossRef]
  21. Takahashi, N.; Nyvad, B. The role of bacteria in the caries process: Ecological perspectives. J. Dent. Res. 2011, 90, 294–303. [Google Scholar] [CrossRef]
  22. Fejerskov, O. Changing paradigms in concepts on dental caries: Consequences for oral health care. Caries Res. 2004, 38, 182–191. [Google Scholar] [CrossRef] [PubMed]
  23. Kidd, E.A.; Fejerskov, O. What constitutes dental caries? Histopathology of carious enamel and dentin related to the action of cariogenic biofilms. J. Dent. Res. 2004, 83, C35–C38. [Google Scholar] [CrossRef] [PubMed]
  24. Selwitz, R.H.; Ismail, A.I.; Pitts, N.B. Dental caries. Lancet 2007, 369, 51–59. [Google Scholar] [CrossRef]
  25. Schmidt, J.C.; Zaugg, C.; Weiger, R.; Walter, C. Brushing without brushing?—A review of the efficacy of powered toothbrushes in noncontact biofilm removal. Clin. Oral Investig. 2013, 17, 687–709. [Google Scholar] [CrossRef]
  26. Hall, C.W.; Mah, T.F. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol. Rev. 2017, 41, 276–301. [Google Scholar] [CrossRef]
  27. Sedghi, L.; DiMassa, V.; Harrington, A.; Lynch, S.V.; Kapila, Y.L. The oral microbiome: Role of key organisms and complex networks in oral health and disease. Periodontol 2000 2021, 87, 107–131. [Google Scholar] [CrossRef]
  28. Kolenbrander, P.E.; Andersen, R.N.; Blehert, D.S.; Egland, P.G.; Foster, J.S.; Palmer, R.J., Jr. Communication among oral bacteria. Microbiol. Mol. Biol. Rev. 2002, 66, 486–505. [Google Scholar] [CrossRef] [Green Version]
  29. Palmer, R.J., Jr.; Gordon, S.M.; Cisar, J.O.; Kolenbrander, P.E. Coaggregation-mediated interactions of streptococci and actinomyces detected in initial human dental plaque. J. Bacteriol. 2003, 185, 3400–3409. [Google Scholar] [CrossRef] [Green Version]
  30. Kolenbrander, P.E.; Palmer, R.J., Jr.; Periasamy, S.; Jakubovics, N.S. Oral multispecies biofilm development and the key role of cell-cell distance. Nat. Rev. Microbiol. 2010, 8, 471–480. [Google Scholar] [CrossRef]
  31. Sun, Z.; Xi, J.; Yang, C.; Cong, W. Quorum sensing regulation methods and their effects on biofilm in biological waste treatment systems: A review. Front. Environ. Sci. Eng. 2022, 16, 87. [Google Scholar] [CrossRef]
  32. Kolenbrander, P.E.; Palmer, R.J., Jr.; Rickard, A.H.; Jakubovics, N.S.; Chalmers, N.I.; Diaz, P.I. Bacterial interactions and successions during plaque development. Periodontol 2000 2006, 42, 47–79. [Google Scholar] [CrossRef] [PubMed]
  33. Huang, R.; Li, M.; Gregory, R.L. Bacterial interactions in dental biofilm. Virulence 2011, 2, 435–444. [Google Scholar] [CrossRef] [PubMed]
  34. Diaz, P.I.; Valm, A.M. Microbial Interactions in Oral Communities Mediate Emergent Biofilm Properties. J. Dent. Res. 2020, 99, 18–25. [Google Scholar] [CrossRef] [PubMed]
  35. Mark Welch, J.L.; Rossetti, B.J.; Rieken, C.W.; Dewhirst, F.E.; Borisy, G.G. Biogeography of a human oral microbiome at the micron scale. Proc. Natl. Acad. Sci. USA 2016, 113, E791–E800. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Kreth, J.; Zhang, Y.; Herzberg, M.C. Streptococcal antagonism in oral biofilms: Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus mutans. J. Bacteriol. 2008, 190, 4632–4640. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Kreth, J.; Merritt, J.; Qi, F. Bacterial and host interactions of oral streptococci. DNA Cell Biol. 2009, 28, 397–403. [Google Scholar] [CrossRef]
  38. Marsh, P.D.; Zaura, E. Dental biofilm: Ecological interactions in health and disease. J. Clin. Periodontol. 2017, 44 (Suppl. 18), S12–S22. [Google Scholar] [CrossRef]
  39. Lamont, R.J.; Koo, H.; Hajishengallis, G. The oral microbiota: Dynamic communities and host interactions. Nat. Rev. Microbiol. 2018, 16, 745–759. [Google Scholar] [CrossRef]
  40. Chen, X.; Daliri, E.B.; Tyagi, A.; Oh, D.H. Cariogenic Biofilm: Pathology-Related Phenotypes and Targeted Therapy. Microorganisms 2021, 9, 1311. [Google Scholar] [CrossRef]
  41. Jakubovics, N.S.; Yassin, S.A.; Rickard, A.H. Community interactions of oral streptococci. Adv. Appl. Microbiol. 2014, 87, 43–110. [Google Scholar] [CrossRef]
  42. Ho, M.H.; Lamont, R.J.; Xie, H. A novel peptidic inhibitor derived from Streptococcus cristatus ArcA attenuates virulence potential of Porphyromonas gingivalis. Sci. Rep. 2017, 7, 16217. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Wright, C.J.; Burns, L.H.; Jack, A.A.; Back, C.R.; Dutton, L.C.; Nobbs, A.H.; Lamont, R.J.; Jenkinson, H.F. Microbial interactions in building of communities. Mol. Oral Microbiol. 2013, 28, 83–101. [Google Scholar] [CrossRef] [PubMed]
  44. Wu, J.; Xie, H. Role of arginine deiminase of Streptococcus cristatus in Porphyromonas gingivalis colonization. Antimicrob. Agents Chemother. 2010, 54, 4694–4698. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Zhu, L.; Kreth, J. The role of hydrogen peroxide in environmental adaptation of oral microbial communities. Oxid. Med. Cell Longev. 2012, 2012, 717843. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Jakubovics, N.S.; Gill, S.R.; Vickerman, M.M.; Kolenbrander, P.E. Role of hydrogen peroxide in competition and cooperation between Streptococcus gordonii and Actinomyces naeslundii. FEMS Microbiol. Ecol. 2008, 66, 637–644. [Google Scholar] [CrossRef] [Green Version]
  47. Perera, D.; McLean, A.; Morillo-Lopez, V.; Cloutier-Leblanc, K.; Almeida, E.; Cabana, K.; Mark Welch, J.; Ramsey, M. Mechanisms underlying interactions between two abundant oral commensal bacteria. ISME J. 2022, 16, 948–957. [Google Scholar] [CrossRef]
  48. Huang, X.; Browngardt, C.M.; Jiang, M.; Ahn, S.J.; Burne, R.A.; Nascimento, M.M. Diversity in Antagonistic Interactions between Commensal Oral Streptococci and Streptococcus mutans. Caries Res. 2018, 52, 88–101. [Google Scholar] [CrossRef] [PubMed]
  49. Bondonno, C.P.; Liu, A.H.; Croft, K.D.; Considine, M.J.; Puddey, I.B.; Woodman, R.J.; Hodgson, J.M. Antibacterial mouthwash blunts oral nitrate reduction and increases blood pressure in treated hypertensive men and women. Am. J. Hypertens. 2015, 28, 572–575. [Google Scholar] [CrossRef] [Green Version]
  50. Kapil, V.; Haydar, S.M.; Pearl, V.; Lundberg, J.O.; Weitzberg, E.; Ahluwalia, A. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic. Biol. Med. 2013, 55, 93–100. [Google Scholar] [CrossRef] [Green Version]
  51. Buskermolen, J.K.; Janus, M.M.; Roffel, S.; Krom, B.P.; Gibbs, S. Saliva-Derived Commensal and Pathogenic Biofilms in a Human Gingiva Model. J. Dent. Res. 2018, 97, 201–208. [Google Scholar] [CrossRef] [Green Version]
  52. Vyhnalova, T.; Danek, Z.; Gachova, D.; Linhartova, P.B. The Role of the Oral Microbiota in the Etiopathogenesis of Oral Squamous Cell Carcinoma. Microorganisms 2021, 9, 1549. [Google Scholar] [CrossRef] [PubMed]
  53. Zhang, G.; Chen, R.; Rudney, J.D. Streptococcus cristatus attenuates Fusobacterium nucleatum-induced interleukin-8 expression in oral epithelial cells. J. Periodontal Res. 2008, 43, 408–416. [Google Scholar] [CrossRef] [PubMed]
  54. Hosseini, S.S.; Goudarzi, H.; Ghalavand, Z.; Hajikhani, B.; Rafeieiatani, Z.; Hakemi-Vala, M. Anti-proliferative effects of cell wall, cytoplasmic extract of Lactococcus lactis and nisin through down-regulation of cyclin D1 on SW480 colorectal cancer cell line. Iran J. Microbiol. 2020, 12, 424–430. [Google Scholar] [CrossRef] [PubMed]
  55. Ahmadi, S.; Ghollasi, M.; Hosseini, H.M. The apoptotic impact of nisin as a potent bacteriocin on the colon cancer cells. Microb. Pathog. 2017, 111, 193–197. [Google Scholar] [CrossRef]
  56. Radaic, A.; Ye, C.; Parks, B.; Gao, L.; Kuraji, R.; Malone, E.; Kamarajan, P.; Zhan, L.; Kapila, Y.L. Modulation of pathogenic oral biofilms towards health with nisin probiotic. J. Oral Microbiol. 2020, 12, 1809302. [Google Scholar] [CrossRef] [PubMed]
  57. Tong, Z.; Dong, L.; Zhou, L.; Tao, R.; Ni, L. Nisin inhibits dental caries-associated microorganism in vitro. Peptides 2010, 31, 2003–2008. [Google Scholar] [CrossRef] [PubMed]
  58. Tong, Z.; Ni, L.; Ling, J. Antibacterial peptide nisin: A potential role in the inhibition of oral pathogenic bacteria. Peptides 2014, 60, 32–40. [Google Scholar] [CrossRef]
  59. Sanz, M.; Beighton, D.; Curtis, M.A.; Cury, J.A.; Dige, I.; Dommisch, H.; Ellwood, R.; Giacaman, R.A.; Herrera, D.; Herzberg, M.C.; et al. Role of microbial biofilms in the maintenance of oral health and in the development of dental caries and periodontal diseases. Consensus report of group 1 of the Joint EFP/ORCA workshop on the boundaries between caries and periodontal disease. J. Clin. Periodontol. 2017, 44 (Suppl. 18), S5–S11. [Google Scholar] [CrossRef]
  60. Yoo, S.-M.; Ahn, G.-S. Correlation of Oral Microorganism and Carboxylic Acid in Oral Cavity. Int. J. Clin. Prev. Dent. 2015, 11, 6. [Google Scholar] [CrossRef]
  61. Cugini, C.; Ramasubbu, N.; Tsiagbe, V.K.; Fine, D.H. Dysbiosis From a Microbial and Host Perspective Relative to Oral Health and Disease. Front. Microbiol. 2021, 12, 617485. [Google Scholar] [CrossRef]
  62. Takenaka, S.; Ohsumi, T.; Noiri, Y. Evidence-based strategy for dental biofilms: Current evidence of mouthwashes on dental biofilm and gingivitis. Jpn Dent. Sci. Rev. 2019, 55, 33–40. [Google Scholar] [CrossRef] [PubMed]
  63. Socransky, S.S.; Manganiello, A.D.; Propas, D.; Oram, V.; van Houte, J. Bacteriological studies of developing supragingival dental plaque. J. Periodontal Res. 1977, 12, 90–106. [Google Scholar] [CrossRef] [PubMed]
  64. Nyvad, B.; Kilian, M. Microbiology of the early colonization of human enamel and root surfaces in vivo. Scand. J. Dent. Res. 1987, 95, 369–380. [Google Scholar] [CrossRef] [PubMed]
  65. Moran, J.; Addy, M.; Newcombe, R.; Warren, P. The comparative effects on plaque regrowth of phenolic chlorhexidine and anti-adhesive mouthrinses. J. Clin. Periodontol. 1995, 22, 929–934. [Google Scholar] [CrossRef] [PubMed]
  66. Han, S.; Abiko, Y.; Washio, J.; Luo, Y.; Zhang, L.; Takahashi, N. Green Tea-Derived Epigallocatechin Gallate Inhibits Acid Production and Promotes the Aggregation of Streptococcus mutans and Non-Mutans Streptococci. Caries Res. 2021, 55, 205–214. [Google Scholar] [CrossRef]
  67. Wu, C.D.; Huang, E.; Li, W.; White, M.; Jung, S.; Xie, Q. Beverages Containing Plant-Derived Polyphenols Inhibit Growth and Biofilm Formation of Streptococcus mutans and Children’s Supragingival Plaque Bacteria. Beverages 2021, 7, 43. [Google Scholar] [CrossRef]
  68. Palombo, E.A. Traditional Medicinal Plant Extracts and Natural Products with Activity against Oral Bacteria: Potential Application in the Prevention and Treatment of Oral Diseases. Evid. Based Complement. Alternat. Med. 2011, 2011, 680354. [Google Scholar] [CrossRef] [Green Version]
  69. Souissi, M.; Ben Lagha, A.; Chaieb, K.; Grenier, D. Effect of a Berry Polyphenolic Fraction on Biofilm Formation, Adherence Properties and Gene Expression of Streptococcus mutans and Its Biocompatibility with Oral Epithelial Cells. Antibiotics 2021, 10, 46. [Google Scholar] [CrossRef]
  70. Yamanaka, A.; Kimizuka, R.; Kato, T.; Okuda, K. Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation. Oral. Microbiol. Immunol. 2004, 19, 150–154. [Google Scholar] [CrossRef]
  71. Rahim, Z.H.; Khan, H.B. Comparative studies on the effect of crude aqueous (CA) and solvent (CM) extracts of clove on the cariogenic properties of Streptococcus mutans. J. Oral Sci. 2006, 48, 117–123. [Google Scholar] [CrossRef] [Green Version]
  72. Karygianni, L.; Cecere, M.; Argyropoulou, A.; Hellwig, E.; Skaltsounis, A.L.; Wittmer, A.; Tchorz, J.P.; Al-Ahmad, A. Compounds from Olea europaea and Pistacia lentiscus inhibit oral microbial growth. BMC Complement. Altern. Med. 2019, 19, 51. [Google Scholar] [CrossRef] [PubMed]
  73. Philip, N.; Bandara, H.; Leishman, S.J.; Walsh, L.J. Inhibitory effects of fruit berry extracts on Streptococcus mutans biofilms. Eur. J. Oral. Sci. 2019, 127, 122–129. [Google Scholar] [CrossRef] [Green Version]
  74. Vijayakumar, A.; Sarveswari, H.B.; Vasudevan, S.; Shanmugam, K.; Solomon, A.P.; Neelakantan, P. Baicalein Inhibits Streptococcus mutans Biofilms and Dental Caries-Related Virulence Phenotypes. Antibiotics 2021, 10, 215. [Google Scholar] [CrossRef] [PubMed]
  75. Zhang, Z.; Liu, Y.; Lu, M.; Lyu, X.; Gong, T.; Tang, B.; Wang, L.; Zeng, J.; Li, Y. Rhodiola rosea extract inhibits the biofilm formation and the expression of virulence genes of cariogenic oral pathogen Streptococcus mutans. Arch. Oral Biol. 2020, 116, 104762. [Google Scholar] [CrossRef]
  76. Shafiei, Z.; Rahim, Z.H.A.; Philip, K.; Thurairajah, N.; Yaacob, H. Potential effects of Psidium sp., Mangifera sp., Mentha sp. and its mixture (PEM) in reducing bacterial populations in biofilms, adherence and acid production of S. sanguinis and S. mutans. Arch. Oral Biol. 2020, 109, 104554. [Google Scholar] [CrossRef] [PubMed]
  77. Shafiei, Z.; Haji Abdul Rahim, Z.; Philip, K.; Thurairajah, N. Antibacterial and anti-adherence effects of a plant extract mixture (PEM) and its individual constituent extracts (Psidium sp., Mangifera sp., and Mentha sp.) on single- and dual-species biofilms. PeerJ 2016, 4, e2519. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  78. Lee, H.J.; Kim, S.C.; Kim, J.; Do, A.; Han, S.Y.; Lee, B.D.; Lee, H.H.; Lee, M.C.; Lee, S.H.; Oh, T.; et al. Synergistic inhibition of Streptococcal biofilm by ribose and xylitol. Arch. Oral Biol. 2015, 60, 304–312. [Google Scholar] [CrossRef] [PubMed]
  79. Taheri, J.B.; Azimi, S.; Rafieian, N.; Zanjani, H.A. Herbs in dentistry. Int. Dent. J. 2011, 61, 287–296. [Google Scholar] [CrossRef]
  80. Nascimento, M.M.; Alvarez, A.J.; Huang, X.; Browngardt, C.; Jenkins, R.; Sinhoreti, M.C.; Ribeiro, A.P.D.; Dilbone, D.A.; Richards, V.P.; Garrett, T.J.; et al. Metabolic Profile of Supragingival Plaque Exposed to Arginine and Fluoride. J. Dent. Res. 2019, 98, 1245–1252. [Google Scholar] [CrossRef]
  81. Skinner, J.; Byun, R.; Blinkhorn, A.; Johnson, G. Sugary drink consumption and dental caries in New South Wales teenagers. Aust. Dent. J. 2015, 60, 169–175. [Google Scholar] [CrossRef]
  82. Tahmassebi, J.F.; Duggal, M.S.; Malik-Kotru, G.; Curzon, M.E. Soft drinks and dental health: A review of the current literature. J. Dent. 2006, 34, 2–11. [Google Scholar] [CrossRef] [PubMed]
  83. Chen, L.; Chakraborty, B.; Zou, J.; Burne, R.A.; Zeng, L. Amino Sugars Modify Antagonistic Interactions between Commensal Oral Streptococci and Streptococcus mutans. Appl. Environ. Microbiol. 2019, 85, e00370-19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Moye, Z.D.; Burne, R.A.; Zeng, L. Uptake and metabolism of N-acetylglucosamine and glucosamine by Streptococcus mutans. Appl. Environ. Microbiol. 2014, 80, 5053–5067. [Google Scholar] [CrossRef] [Green Version]
  85. Roberfroid, M. Prebiotics: The concept revisited. J. Nutr. 2007, 137, 830S–837S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Velmurugan, S.; Gan, J.M.; Rathod, K.S.; Khambata, R.S.; Ghosh, S.M.; Hartley, A.; Van Eijl, S.; Sagi-Kiss, V.; Chowdhury, T.A.; Curtis, M.; et al. Dietary nitrate improves vascular function in patients with hypercholesterolemia: A randomized, double-blind, placebo-controlled study. Am. J. Clin. Nutr. 2016, 103, 25–38. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Jockel-Schneider, Y.; Schlagenhauf, U.; Stolzel, P.; Gossner, S.; Carle, R.; Ehmke, B.; Prior, K.; Hagenfeld, D. Nitrate-rich diet alters the composition of the oral microbiota in periodontal recall patients. J. Periodontol. 2021, 92, 1536–1545. [Google Scholar] [CrossRef] [PubMed]
  88. Kolderman, E.; Bettampadi, D.; Samarian, D.; Dowd, S.E.; Foxman, B.; Jakubovics, N.S.; Rickard, A.H. L-arginine destabilizes oral multi-species biofilm communities developed in human saliva. PLoS ONE 2015, 10, e0121835. [Google Scholar] [CrossRef] [Green Version]
  89. Huang, X.; Zhang, K.; Deng, M.; Exterkate, R.A.M.; Liu, C.; Zhou, X.; Cheng, L.; Ten Cate, J.M. Effect of arginine on the growth and biofilm formation of oral bacteria. Arch. Oral Biol. 2017, 82, 256–262. [Google Scholar] [CrossRef]
  90. Huang, X.; Schulte, R.M.; Burne, R.A.; Nascimento, M.M. Characterization of the arginolytic microflora provides insights into pH homeostasis in human oral biofilms. Caries Res. 2015, 49, 165–176. [Google Scholar] [CrossRef] [Green Version]
  91. Velsko, I.M.; Chakraborty, B.; Nascimento, M.M.; Burne, R.A.; Richards, V.P. Species Designations Belie Phenotypic and Genotypic Heterogeneity in Oral Streptococci. mSystems 2018, 3, e00158-18. [Google Scholar] [CrossRef] [Green Version]
  92. Agnello, M.; Cen, L.; Tran, N.C.; Shi, W.; McLean, J.S.; He, X. Arginine Improves pH Homeostasis via Metabolism and Microbiome Modulation. J. Dent. Res. 2017, 96, 924–930. [Google Scholar] [CrossRef] [PubMed]
  93. Kamaguch, A.; Nakayama, K.; Ohyama, T.; Watanabe, T.; Okamoto, M.; Baba, H. Coaggregation of Porphyromonas gingivalis and Prevotella intermedia. Microbiol. Immunol. 2001, 45, 649–656. [Google Scholar] [CrossRef] [PubMed]
  94. Tester, R.F.; Al-Ghazzewi, F.H. A preliminary study of the synbiotic effects of konjac glucomannan hydrolysates (GMH) and lactobacilli on the growth of the oral bacterium Streptococcus mutans. Nutr. Food Sci. 2011, 41, 5. [Google Scholar] [CrossRef]
  95. Bijle, M.N.; Ekambaram, M.; Lo, E.C.M.; Yiu, C.K.Y. Synbiotics in caries prevention: A scoping review. PLoS ONE 2020, 15, e0237547. [Google Scholar] [CrossRef] [PubMed]
  96. Slomka, V.; Hernandez-Sanabria, E.; Herrero, E.R.; Zaidel, L.; Bernaerts, K.; Boon, N.; Quirynen, M.; Teughels, W. Nutritional stimulation of commensal oral bacteria suppresses pathogens: The prebiotic concept. J. Clin. Periodontol. 2017, 44, 344–352. [Google Scholar] [CrossRef]
  97. Gasmi Benahmed, A.; Gasmi, A.; Arshad, M.; Shanaida, M.; Lysiuk, R.; Peana, M.; Pshyk-Titko, I.; Adamiv, S.; Shanaida, Y.; Bjorklund, G. Health benefits of xylitol. Appl. Microbiol. Biotechnol. 2020, 104, 7225–7237. [Google Scholar] [CrossRef]
  98. Haukioja, A.; Soderling, E.; Tenovuo, J. Acid production from sugars and sugar alcohols by probiotic lactobacilli and bifidobacteria in vitro. Caries Res. 2008, 42, 449–453. [Google Scholar] [CrossRef]
  99. Hedberg, M.; Hasslof, P.; Sjostrom, I.; Twetman, S.; Stecksen-Blicks, C. Sugar fermentation in probiotic bacteria—An in vitro study. Oral Microbiol. Immunol. 2008, 23, 482–485. [Google Scholar] [CrossRef]
  100. Salli, K.M.; Forssten, S.D.; Lahtinen, S.J.; Ouwehand, A.C. Influence of sucrose and xylitol on an early Streptococcus mutans biofilm in a dental simulator. Arch. Oral Biol. 2016, 70, 39–46. [Google Scholar] [CrossRef]
  101. Kaur, K.; Nekkanti, S.; Madiyal, M.; Choudhary, P. Effect of chewing gums containing probiotics and xylitol on oral health in children: A randomized controlled trial. J. Int. Oral Health 2018, 10, 7. [Google Scholar] [CrossRef]
  102. Kojima, Y.; Ohshima, T.; Seneviratne, C.J.; Maeda, N. Combining prebiotics and probiotics to develop novel synbiotics that suppress oral pathogens. J. Oral Biosci. 2016, 58, 6. [Google Scholar] [CrossRef]
  103. Cleaver, L.M.; Moazzez, R.V.; Carpenter, G.H. Evidence for Proline Utilization by Oral Bacterial Biofilms Grown in Saliva. Front. Microbiol. 2020, 11, 619968. [Google Scholar] [CrossRef] [PubMed]
  104. Christgen, S.L.; Becker, D.F. Role of Proline in Pathogen and Host Interactions. Antioxid. Redox Signal. 2019, 30, 683–709. [Google Scholar] [CrossRef]
  105. Culp, D.J.; Hull, W.; Bremgartner, M.J.; Atherly, T.A.; Christian, K.N.; Killeen, M.; Dupuis, M.R.; Schultz, A.C.; Chakraborty, B.; Lee, K.; et al. In Vivo Colonization with Candidate Oral Probiotics Attenuates Colonization and Virulence of Streptococcus mutans. Appl. Environ. Microbiol. 2020, 87, e02490-20. [Google Scholar] [CrossRef]
  106. Amargianitakis, M.; Antoniadou, M.; Rahiotis, C.; Varzakas, T. Probiotics, Prebiotics, Synbiotics and Dental Caries. New Perspectives, Suggestions, and Patient Coaching Approach for a Cavity-Free Mouth. Appl. Sci. 2021, 11, 5472. [Google Scholar] [CrossRef]
  107. Sivamaruthi, B.S.; Kesika, P.; Chaiyasut, C. A Review of the Role of Probiotic Supplementation in Dental Caries. Probiotics Antimicrob. Proteins 2020, 12, 1300–1309. [Google Scholar] [CrossRef]
  108. Zheng, L.; Chen, Z.; Itzek, A.; Herzberg, M.C.; Kreth, J. CcpA regulates biofilm formation and competence in Streptococcus gordonii. Mol. Oral Microbiol. 2012, 27, 83–94. [Google Scholar] [CrossRef]
  109. Alforaidi, S.; Bresin, A.; Almosa, N.; Lehrkinder, A.; Lingstrom, P. Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients. BMC Microbiol. 2021, 21, 271. [Google Scholar] [CrossRef]
  110. Chen, Z.; Schlafer, S.; Gostemeyer, G.; Schwendicke, F. Probiotic Effects on Multispecies Biofilm Composition, Architecture, and Caries Activity In Vitro. Microorganisms 2020, 8, 1272. [Google Scholar] [CrossRef]
  111. Sliepen, I.; Van Damme, J.; Van Essche, M.; Loozen, G.; Quirynen, M.; Teughels, W. Microbial interactions influence inflammatory host cell responses. J. Dent. Res. 2009, 88, 1026–1030. [Google Scholar] [CrossRef]
  112. Cosseau, C.; Devine, D.A.; Dullaghan, E.; Gardy, J.L.; Chikatamarla, A.; Gellatly, S.; Yu, L.L.; Pistolic, J.; Falsafi, R.; Tagg, J.; et al. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect. Immun. 2008, 76, 4163–4175. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Garcia-Mendoza, A.; Liebana, J.; Castillo, A.M.; de la Higuera, A.; Piedrola, G. Evaluation of the capacity of oral streptococci to produce hydrogen peroxide. J. Med. Microbiol. 1993, 39, 434–439. [Google Scholar] [CrossRef] [PubMed]
  114. Thurnheer, T.; Belibasakis, G.N. Streptococcus oralis maintains homeostasis in oral biofilms by antagonizing the cariogenic pathogen Streptococcus mutans. Mol. Oral Microbiol. 2018, 33, 234–239. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  115. Wescombe, P.A.; Heng, N.C.; Burton, J.P.; Chilcott, C.N.; Tagg, J.R. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. Future Microbiol. 2009, 4, 819–835. [Google Scholar] [CrossRef] [Green Version]
  116. Burton, J.P.; Drummond, B.K.; Chilcott, C.N.; Tagg, J.R.; Thomson, W.M.; Hale, J.D.F.; Wescombe, P.A. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: A randomized double-blind, placebo-controlled trial. J. Med. Microbiol. 2013, 62, 875–884. [Google Scholar] [CrossRef]
  117. Zare Javid, A.; Amerian, E.; Basir, L.; Ekrami, A.; Haghighizadeh, M.H.; Maghsoumi-Norouzabad, L. Effects of the Consumption of Probiotic Yogurt Containing Bifidobacterium lactis Bb12 on the Levels of Streptococcus mutans and Lactobacilli in Saliva of Students with Initial Stages of Dental Caries: A Double-Blind Randomized Controlled Trial. Caries Res. 2020, 54, 68–74. [Google Scholar] [CrossRef]
  118. Tester, R.F.; Al-Ghazzewi, F.H. Role of prebiotics and probiotics in oral health. Nutr. Food Sci. 2018, 48, 14. [Google Scholar] [CrossRef]
  119. Jang, H.J.; Kim, J.H.; Lee, N.K.; Paik, H.D. Inhibitory effects of Lactobacillus brevis KU15153 against Streptococcus mutans KCTC 5316 causing dental caries. Microb. Pathog. 2021, 157, 104938. [Google Scholar] [CrossRef]
  120. Culp, D.J.; Hull, W.; Schultz, A.C.; Bryant, A.S.; Lizarraga, C.A.; Dupuis, M.R.; Chakraborty, B.; Lee, K.; Burne, R.A. Testing of candidate probiotics to prevent dental caries induced by Streptococcus mutans in a mouse model. J. Appl. Microbiol. 2022, 132, 3853–3869. [Google Scholar] [CrossRef]
  121. Hoffmann, A.; Fischer, J.T.; Daniels, R. Development of probiotic orodispersible tablets using mucoadhesive polymers for buccal mucoadhesion. Drug Dev. Ind. Pharm. 2020, 46, 1753–1762. [Google Scholar] [CrossRef]
  122. Călinoiu, L.F.; Ştefănescu, B.E.; Pop, I.D.; Muntean, L.; Vodnar, D.C. Chitosan Coating Applications in Probiotic Microencapsulation. Coatings 2019, 9, 194. [Google Scholar] [CrossRef] [Green Version]
  123. Yeung, T.W.; Ucok, E.F.; Tiani, K.A.; McClements, D.J.; Sela, D.A. Microencapsulation in Alginate and Chitosan Microgels to Enhance Viability of Bifidobacterium longum for Oral Delivery. Front. Microbiol. 2016, 7, 494. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Salas-Jara, M.J.; Ilabaca, A.; Vega, M.; Garcia, A. Biofilm Forming Lactobacillus: New Challenges for the Development of Probiotics. Microorganisms 2016, 4, 35. [Google Scholar] [CrossRef] [PubMed]
  125. Erdelyi, L.; Fenyvesi, F.; Gal, B.; Haimhoffer, A.; Vasvari, G.; Budai, I.; Remenyik, J.; Bereczki, I.; Feher, P.; Ujhelyi, Z.; et al. Investigation of the Role and Effectiveness of Chitosan Coating on Probiotic Microcapsules. Polymers 2022, 14, 1664. [Google Scholar] [CrossRef]
  126. Kiew, T.Y.; Cheow, W.S.; Hadinoto, K. Importance of biofilm age and growth medium on the viability of probiotic capsules containing Lactobacillus rhamnosus GG biofilm. LWT-Food Sci. Technol. 2014, 59, 8. [Google Scholar] [CrossRef]
  127. Muras, A.; Mallo, N.; Otero-Casal, P.; Pose-Rodriguez, J.M.; Otero, A. Quorum sensing systems as a new target to prevent biofilm-related oral diseases. Oral Dis. 2022, 28, 307–313. [Google Scholar] [CrossRef]
  128. Cho, Y.J.; Song, H.Y.; Ben Amara, H.; Choi, B.K.; Eunju, R.; Cho, Y.A.; Seol, Y.; Lee, Y.; Ku, Y.; Rhyu, I.C.; et al. In Vivo Inhibition of Porphyromonas gingivalis Growth and Prevention of Periodontitis with Quorum-Sensing Inhibitors. J. Periodontol. 2016, 87, 1075–1082. [Google Scholar] [CrossRef] [Green Version]
  129. Mukherjee, S.; Bassler, B.L. Bacterial quorum sensing in complex and dynamically changing environments. Nat. Rev. Microbiol. 2019, 17, 371–382. [Google Scholar] [CrossRef]
  130. Inaba, T.; Obana, N.; Habe, H.; Nomura, N. Biofilm Formation by Streptococcus mutans is Enhanced by Indole via the Quorum Sensing Pathway. Microbes Environ. 2020, 35, ME19164. [Google Scholar] [CrossRef]
  131. Muras, A.; Mayer, C.; Romero, M.; Camino, T.; Ferrer, M.D.; Mira, A.; Otero, A. Inhibition of Steptococcus mutans biofilm formation by extracts of Tenacibaculum sp. 20J, a bacterium with wide-spectrum quorum quenching activity. J. Oral Microbiol. 2018, 10, 1429788. [Google Scholar] [CrossRef] [Green Version]
  132. Dong, Y.H.; Zhang, L.H. Quorum sensing and quorum-quenching enzymes. J. Microbiol. 2005, 43, 101–109. [Google Scholar] [PubMed]
  133. Choi, B.-K. Quorum Sensing Regulation of Biofilm Formation by Periodontal Pathogens. Int. J. Oral Biol. 2018, 43, 6. [Google Scholar] [CrossRef]
  134. Huang, Y.; Liu, Y.; Shah, S.; Kim, D.; Simon-Soro, A.; Ito, T.; Hajfathalian, M.; Li, Y.; Hsu, J.C.; Nieves, L.M.; et al. Precision targeting of bacterial pathogen via bi-functional nanozyme activated by biofilm microenvironment. Biomaterials 2021, 268, 120581. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Illustration exemplifying the possible development of multispecies biofilms. Scanning electron microscopy corresponds to an in vitro supragingival biofilm model of (a) 3, (b) 12, (c) 24, and (d) 48 h of evolution (to methodology [9]): (a) initial colonization of a substratum covered in an acquired film composed of polysaccharides and proteins. In vitro, various bacteria of coccoid and bacillary morphology can be seen on the surface after 3 h of biofilm process initiation; cell division can be appreciated mainly in coccoid bacteria (green arrows; scale bar = 9 µm); (b) rapid growth and division of initial colonizers and production of extracellular polysaccharide (EPS) leading to the development of microcolonies from several bacterial species—green arrows point to EPS surrounding bacteria in a microcolony after 12 h of biofilm development in vitro, which is identifiable in the image as a compact mass of greater brightness—(scale bar = 5 µm); (c) coadhesion and coaggregation of bacteria into a young multispecies biofilm—after 24 h of in vitro evolution, the surface appeared to be covered by bacteria consisting primarily of a larger colonies—outward-growing masses of bacterial cells alternating with flat homogenous layers of cells (scale bar = 50 µm); and (d) maturation of the multispecies biofilm—after 48 h of in vitro incubation, biofilm demonstrated the characteristic organization of these communities: covering the surface with bacteria clusters, forming stacks, and showing channels inside the structure—(scale bar = 20 µm).
Figure 1. Illustration exemplifying the possible development of multispecies biofilms. Scanning electron microscopy corresponds to an in vitro supragingival biofilm model of (a) 3, (b) 12, (c) 24, and (d) 48 h of evolution (to methodology [9]): (a) initial colonization of a substratum covered in an acquired film composed of polysaccharides and proteins. In vitro, various bacteria of coccoid and bacillary morphology can be seen on the surface after 3 h of biofilm process initiation; cell division can be appreciated mainly in coccoid bacteria (green arrows; scale bar = 9 µm); (b) rapid growth and division of initial colonizers and production of extracellular polysaccharide (EPS) leading to the development of microcolonies from several bacterial species—green arrows point to EPS surrounding bacteria in a microcolony after 12 h of biofilm development in vitro, which is identifiable in the image as a compact mass of greater brightness—(scale bar = 5 µm); (c) coadhesion and coaggregation of bacteria into a young multispecies biofilm—after 24 h of in vitro evolution, the surface appeared to be covered by bacteria consisting primarily of a larger colonies—outward-growing masses of bacterial cells alternating with flat homogenous layers of cells (scale bar = 50 µm); and (d) maturation of the multispecies biofilm—after 48 h of in vitro incubation, biofilm demonstrated the characteristic organization of these communities: covering the surface with bacteria clusters, forming stacks, and showing channels inside the structure—(scale bar = 20 µm).
Antibiotics 11 00880 g001
Figure 2. Summary of possible therapeutic approaches presented in the revision aimed at strategies to combat caries by maintaining the integrity of biofilm and homeostasis during the rapid phase of supragingival plaque formation.
Figure 2. Summary of possible therapeutic approaches presented in the revision aimed at strategies to combat caries by maintaining the integrity of biofilm and homeostasis during the rapid phase of supragingival plaque formation.
Antibiotics 11 00880 g002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Hernández, P.; Sánchez, M.C.; Llama-Palacios, A.; Ciudad, M.J.; Collado, L. Strategies to Combat Caries by Maintaining the Integrity of Biofilm and Homeostasis during the Rapid Phase of Supragingival Plaque Formation. Antibiotics 2022, 11, 880. https://doi.org/10.3390/antibiotics11070880

AMA Style

Hernández P, Sánchez MC, Llama-Palacios A, Ciudad MJ, Collado L. Strategies to Combat Caries by Maintaining the Integrity of Biofilm and Homeostasis during the Rapid Phase of Supragingival Plaque Formation. Antibiotics. 2022; 11(7):880. https://doi.org/10.3390/antibiotics11070880

Chicago/Turabian Style

Hernández, Paola, María C. Sánchez, Arancha Llama-Palacios, María J. Ciudad, and Luis Collado. 2022. "Strategies to Combat Caries by Maintaining the Integrity of Biofilm and Homeostasis during the Rapid Phase of Supragingival Plaque Formation" Antibiotics 11, no. 7: 880. https://doi.org/10.3390/antibiotics11070880

APA Style

Hernández, P., Sánchez, M. C., Llama-Palacios, A., Ciudad, M. J., & Collado, L. (2022). Strategies to Combat Caries by Maintaining the Integrity of Biofilm and Homeostasis during the Rapid Phase of Supragingival Plaque Formation. Antibiotics, 11(7), 880. https://doi.org/10.3390/antibiotics11070880

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop